These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 26694810

  • 1. Anti-aggressive effects of the selective high-efficacy 'biased' 5-HT₁A receptor agonists F15599 and F13714 in male WTG rats.
    de Boer SF, Newman-Tancredi A.
    Psychopharmacology (Berl); 2016 Mar; 233(6):937-47. PubMed ID: 26694810
    [Abstract] [Full Text] [Related]

  • 2. Divergent effects of the 'biased' 5-HT1 A receptor agonists F15599 and F13714 in a novel object pattern separation task.
    van Goethem NP, Schreiber R, Newman-Tancredi A, Varney M, Prickaerts J.
    Br J Pharmacol; 2015 May; 172(10):2532-43. PubMed ID: 25572672
    [Abstract] [Full Text] [Related]

  • 3. Effects of the Serotonin 5-HT1A Receptor Biased Agonists, F13714 and F15599, on Striatal Neurotransmitter Levels Following L-DOPA Administration in Hemi-Parkinsonian Rats.
    Newman-Tancredi A, Varney MA, McCreary AC.
    Neurochem Res; 2018 May; 43(5):1035-1046. PubMed ID: 29572645
    [Abstract] [Full Text] [Related]

  • 4. Discriminative stimulus properties of the 5-HT1A receptor biased agonists NLX-101 and F13714, in rats trained to discriminate 8-OH-DPAT from saline.
    Broadbear JH, Depoortere RY, Vacy K, Ralph D, Tunstall BJ, Newman-Tancredi A.
    Behav Pharmacol; 2021 Dec 01; 32(8):652-659. PubMed ID: 34751175
    [Abstract] [Full Text] [Related]

  • 5. Activity of serotonin 5-HT(1A) receptor 'biased agonists' in rat models of Parkinson's disease and L-DOPA-induced dyskinesia.
    Iderberg H, McCreary AC, Varney MA, Cenci MA, Newman-Tancredi A.
    Neuropharmacology; 2015 Jun 01; 93():52-67. PubMed ID: 25645393
    [Abstract] [Full Text] [Related]

  • 6. Preferential in vivo action of F15599, a novel 5-HT(1A) receptor agonist, at postsynaptic 5-HT(1A) receptors.
    Lladó-Pelfort L, Assié MB, Newman-Tancredi A, Artigas F, Celada P.
    Br J Pharmacol; 2010 Aug 01; 160(8):1929-40. PubMed ID: 20649591
    [Abstract] [Full Text] [Related]

  • 7. Serotonin 5-HT1A Receptor Biased Agonists Display Differential Anxiolytic Activity in a Rat Social Interaction Model.
    Depoortère R, Bardin L, Varney MA, Newman-Tancredi A.
    ACS Chem Neurosci; 2019 Jul 17; 10(7):3101-3107. PubMed ID: 30929419
    [Abstract] [Full Text] [Related]

  • 8. Aggression-reducing effects of F15599, a novel selective 5-HT1A receptor agonist, after microinjection into the ventral orbital prefrontal cortex, but not in infralimbic cortex in male mice.
    Stein DJ, Miczek KA, Lucion AB, de Almeida RM.
    Psychopharmacology (Berl); 2013 Dec 17; 230(3):375-87. PubMed ID: 23828155
    [Abstract] [Full Text] [Related]

  • 9. Activity of Serotonin 5-HT1A Receptor Biased Agonists in Rat: Anxiolytic and Antidepressant-like properties.
    Jastrzębska-Więsek M, Partyka A, Rychtyk J, Śniecikowska J, Kołaczkowski M, Wesołowska A, Varney MA, Newman-Tancredi A.
    ACS Chem Neurosci; 2018 May 16; 9(5):1040-1050. PubMed ID: 29266914
    [Abstract] [Full Text] [Related]

  • 10. The selective 5-HT1A receptor biased agonists, F15599 and F13714, show antidepressant-like properties after a single administration in the mouse model of unpredictable chronic mild stress.
    Głuch-Lutwin M, Sałaciak K, Gawalska A, Jamrozik M, Sniecikowska J, Newman-Tancredi A, Kołaczkowski M, Pytka K.
    Psychopharmacology (Berl); 2021 Aug 16; 238(8):2249-2260. PubMed ID: 33973045
    [Abstract] [Full Text] [Related]

  • 11. Characterizing the differential roles of striatal 5-HT1A auto- and hetero-receptors in the reduction of l-DOPA-induced dyskinesia.
    Meadows SM, Chambers NE, Conti MM, Bossert SC, Tasber C, Sheena E, Varney M, Newman-Tancredi A, Bishop C.
    Exp Neurol; 2017 Jun 16; 292():168-178. PubMed ID: 28342749
    [Abstract] [Full Text] [Related]

  • 12. 5-HT1A and 5-HT1B receptor agonists and aggression: a pharmacological challenge of the serotonin deficiency hypothesis.
    de Boer SF, Koolhaas JM.
    Eur J Pharmacol; 2005 Dec 05; 526(1-3):125-39. PubMed ID: 16310183
    [Abstract] [Full Text] [Related]

  • 13. Signal transduction and functional selectivity of F15599, a preferential post-synaptic 5-HT1A receptor agonist.
    Newman-Tancredi A, Martel JC, Assié MB, Buritova J, Lauressergues E, Cosi C, Heusler P, Bruins Slot L, Colpaert FC, Vacher B, Cussac D.
    Br J Pharmacol; 2009 Jan 05; 156(2):338-53. PubMed ID: 19154445
    [Abstract] [Full Text] [Related]

  • 14. F15599, a highly selective post-synaptic 5-HT(1A) receptor agonist: in-vivo profile in behavioural models of antidepressant and serotonergic activity.
    Assié MB, Bardin L, Auclair AL, Carilla-Durand E, Depoortère R, Koek W, Kleven MS, Colpaert F, Vacher B, Newman-Tancredi A.
    Int J Neuropsychopharmacol; 2010 Nov 05; 13(10):1285-98. PubMed ID: 20059805
    [Abstract] [Full Text] [Related]

  • 15. F15599, a preferential post-synaptic 5-HT1A receptor agonist: activity in models of cognition in comparison with reference 5-HT1A receptor agonists.
    Depoortère R, Auclair AL, Bardin L, Colpaert FC, Vacher B, Newman-Tancredi A.
    Eur Neuropsychopharmacol; 2010 Sep 05; 20(9):641-54. PubMed ID: 20488670
    [Abstract] [Full Text] [Related]

  • 16. Biased 5-HT1A receptor agonists F13714 and NLX-101 differentially affect pattern separation and neuronal plasticity in rats after acute and chronic treatment.
    van Hagen BTJ, van Goethem NP, Nelissen E, Paes D, Koymans K, van Hoof S, Schreiber R, Varney M, Newman-Tancredi A, Prickaerts J.
    Mol Cell Neurosci; 2022 May 05; 120():103719. PubMed ID: 35283305
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Activation of somatodendritic 5-HT1A autoreceptors reduces the acquisition and expression of cued fear in the rat fear-potentiated startle test.
    Zhao Y, Bijlsma EY, Ter Heegde F, Verdouw MP, Garssen J, Newman-Tancredi A, Groenink L.
    Psychopharmacology (Berl); 2019 Apr 05; 236(4):1171-1185. PubMed ID: 30539269
    [Abstract] [Full Text] [Related]

  • 19. Somatodendritic 5-HT(1A) autoreceptors mediate the anti-aggressive actions of 5-HT(1A) receptor agonists in rats: an ethopharmacological study with S-15535, alnespirone, and WAY-100635.
    de Boer SF, Lesourd M, Mocaër E, Koolhaas JM.
    Neuropsychopharmacology; 2000 Jul 05; 23(1):20-33. PubMed ID: 10869883
    [Abstract] [Full Text] [Related]

  • 20. In vivo electrophysiological and neurochemical effects of the selective 5-HT1A receptor agonist, F13640, at pre- and postsynaptic 5-HT1A receptors in the rat.
    Lladó-Pelfort L, Assié MB, Newman-Tancredi A, Artigas F, Celada P.
    Psychopharmacology (Berl); 2012 May 05; 221(2):261-72. PubMed ID: 22147258
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.